SANGAMO THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $4.33 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.33M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.00M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $5.98M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $7.70M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $4.33M 10-K · filed 2026-03-30 |
| 2024-12-31 | $4.00M 10-K · filed 2026-03-30 |
| 2023-12-31 | $5.98M 10-K · filed 2025-03-17 |
| 2022-12-31 | $7.70M 10-K · filed 2024-03-13 |
| 2021-12-31 | $6.69M 10-K · filed 2023-02-23 |
| 2020-12-31 | $5.32M 10-K · filed 2022-02-24 |
| 2019-12-31 | $4.19M 10-K · filed 2021-02-24 |
| 2018-12-31 | $3.80M 10-K · filed 2020-02-28 |
| 2017-12-31 | $3.17M 10-K · filed 2019-03-01 |
| 2016-12-31 | $8.56M 10-K · filed 2018-03-01 |
| 2015-12-31 | $6.85M 10-K · filed 2017-02-28 |
| 2014-12-31 | $8.17M 10-K · filed 2016-02-18 |
| 2013-12-31 | $7.93M 10-K · filed 2015-02-25 |
| 2012-12-31 | $7.38M 10-K · filed 2014-02-24 |
| 2011-12-31 | $7.36M 10-K · filed 2013-02-26 |